Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription

Microbes and Infection

Volumn 11, Issue 4, 2009, Pages 500-508

  Yamagishi, Makoto ^a   Ishida, Takaomi ^a,b   Miyake, Ariko ^a   Cooper, David A ^c,d   Kelleher, Anthony D ^c,d   Suzuki, Kazuo ^d   Watanabe, Toshiki ^a  

^a Graduate School of Frontier Sciences   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

HIV 1; shRNA; Transcriptional gene silencing

Indexed keywords

AZACITIDINE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; LYSINE; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRICHOSTATIN A;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HETEROCHROMATIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENE; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

ANTI-HIV AGENTS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; GENE SILENCING; HELA CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 64549113392     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.02.003     Document Type: Article

References (29)

1. Finzi D., and Siliciano R.F. Viral dynamics in HIV-1 infection. Cell 93 (1998) 665-671
2. Han Y., Wind-Rotolo M., Yang H.C., Siliciano J.D., and Siliciano R.F. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5 (2007) 95-106
3. Dunne M. Antiretroviral drug development: the challenge of cost and access. AIDS 21 (2007) S73-S79
4. Carr A. Toxicity of antiretroviral therapy and implications for drug development. Nat. Rev. Drug. Discov. 2 (2003) 624-634
5. Bednarik D.P., Cook J.A., and Pitha P.M. Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO J. 9 (1990) 1157-1164
6. Williams S.A., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Verdin E., and Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25 (2006) 139-149
7. du Chéné I., Basyuk E., Lin Y.L., Triboulet R., Knezevich A., Chable-Bessia C., Mettling C., Baillat V., Reynes J., Corbeau P., Bertrand E., Marcello A., Emiliani S., Kiernan R., and Benkirane M. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26 (2007) 424-435
8. Girard A., and Hannon G.J. Conserved themes in small-RNA-mediated transposon control. Trends Cell Biol. 18 (2008) 136-148
9. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
10. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., and Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8 (2002) 681-686
11. Rossi J.J., June C.H., and Kohn D.B. Genetic therapies against HIV. Nat. Biotechnol. 25 (2007) 1444-1454
12. Boden D., Pusch O., Lee F., Tucker L., and Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003) 11531-11535
13. Suzuki K., Shijuuku T., Fukamachi1 T., Zaunders J.J., Guillemin G., Cooper D.A., and Kelleher A.D. Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J. RNAi Gene Silencing 1 (2005) 66-78
14. Suzuki K., Juelich T., Lim H., Ishida T., Watanebe T., Cooper D.A., Rao S., and Kelleher A.D. Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region. J. Biol. Chem. 28 (2008) 23353-23363
15. Lim H.G., Suzuki K., Cooper D.A., and Kelleher A.D. Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro. Mol. Ther. 16 (2008) 565-570
16. Morris K.V., Chan S.W., Jacobsen S.E., and Looney D.J. Small interfering RNA-induced transcriptional silencing in human cells. Science 305 (2004) 1289-1292
17. Castanotto D., Tommasi S., Li M., Li H., Yanow S., Pfeifer G.P., and Rossi J.J. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1 promoter in HeLa cells. Mol. Ther. 12 (2005) 179-183
18. Ting A.H., Schuebel K.E., Herman J.G., and Baylin S.B. Short double-stranded RNA induces transcriptional gene silencing in human cells in the absence of DNA methylation. Nat. Genet. 37 (2005) 906-910
19. Weinberg M.S., Villeneuve L.M., Ehsani A., Amarzguioui M., Aagaard L., Chen Z.X., Riggs A.D., Rossi J.J., and Morris K.V. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12 (2006) 256-262
20. Janowski B.A., Huffman K.E., Schwartz J.C., Ram R., Nordsell R., Shames D.S., Minna J.D., and Corey D.R. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat. Struct. Mol. Biol. 13 (2006) 787-792
21. Kim D.H., Villeneuve L.M., Morris K.V., and Rossi J.J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13 (2006) 793-797
22. Willey R.L., Smith D.H., Lasky L.A., Theodore T.S., Earl P.L., Moss B., Capon D.J., and Martin M.A. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62 (1988) 139-147
23. Brussel A., and Sonigo P. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J. Virol. 77 (2003) 10119-10124
24. Greenberg M., and Bender T. In vitro transcription. Curr. Protoc. Mol. Biol. (1997) 1-11
25. Tanaka J., Ishida T., Choi B.I., Yasuda J., Watanabe T., and Iwakura Y. Latent HIV-1 reactivation in transgenic mice requires cell cycle-dependent demethylation of CREB/ATF sites in the LTR. AIDS 17 (2003) 167-175
26. Kamoi K., Yamamoto K., Misawa A., Miyake A., Ishida T., Tanaka Y., Mochizuki M., and Watanabe T. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR. Retrovirology 3 (2006) 5
27. ter Brake O., Konstantinova P., Ceylan M., and Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14 (2006) 883-892
28. von Eije K.J., ter Brake O., and Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82 (2008) 2895-2903
29. Yan K.S., Yan S., Farooq A., Han A., Zeng L., and Zhou M.M. Structure and conserved RNA binding of the PAZ domain. Nature 426 (2003) 468-474